|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used by operating activities: | |||||
| Depreciation and asset impairment (Note 7) | |||||
| (Recovery of) provision for uncollectible value-added taxes (Note 6) | |||||
| Property concessions impairment (Note 8) | |||||
| Provision for (recovery of) uncollectible value-added taxes (Note 6) | |||||
| Foreign currency transaction loss (income) | |||||
| Stock options issued for compensation (Note 12) | |||||
| Stock options issued for compensation (Note 10) | |||||
| Change in fair value of warrant derivative liability (Note 11) | |||||
| Miscellaneous income (Notes 7 and 9) | |||||
| Concession impairment (Note 8) | |||||
| Shares of common stock issued for services (Note 10) | |||||
| Warrant issuance costs (Note 10) | |||||
| Miscellaneous income | |||||
| Changes in operating assets and liabilities: | |||||
| Other receivables | |||||
| Accounts receivables (Note 4) | |||||
| Prepaid expenses and deposits | |||||
| Due from related party (Note 5) | |||||
| Value-added tax receivable (Note 6) | |||||
| Accounts payable | |||||
| Value-added tax receivable | |||||
| Accrued liabilities and expenses (Note 14) | |||||
| Income tax payable | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchase of equipment | |||||
| Proceeds from sale equipment | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Loan repayment | |||||
| Payment of share issuance costs | |||||
| Proceeds from issuance of common stock, net of offering costs (Note 10) | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash beginning of year | |||||
| Cash, cash equivalents and restricted cash end of year | |||||
| SUPPLEMENTAL CASH FLOW DISCLOSURES: | |||||
| Income taxes paid | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Offering costs included in accounts payable and accrued liabilities | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...